Correlation Between Aurora Cannabis and Organogenesis Holdings
Can any of the company-specific risk be diversified away by investing in both Aurora Cannabis and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aurora Cannabis and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aurora Cannabis and Organogenesis Holdings, you can compare the effects of market volatilities on Aurora Cannabis and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aurora Cannabis with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aurora Cannabis and Organogenesis Holdings.
Diversification Opportunities for Aurora Cannabis and Organogenesis Holdings
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aurora and Organogenesis is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Aurora Cannabis and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and Aurora Cannabis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aurora Cannabis are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of Aurora Cannabis i.e., Aurora Cannabis and Organogenesis Holdings go up and down completely randomly.
Pair Corralation between Aurora Cannabis and Organogenesis Holdings
Considering the 90-day investment horizon Aurora Cannabis is expected to under-perform the Organogenesis Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Aurora Cannabis is 1.54 times less risky than Organogenesis Holdings. The stock trades about -0.28 of its potential returns per unit of risk. The Organogenesis Holdings is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 289.00 in Organogenesis Holdings on August 24, 2024 and sell it today you would earn a total of 113.00 from holding Organogenesis Holdings or generate 39.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aurora Cannabis vs. Organogenesis Holdings
Performance |
| Timeline |
| Aurora Cannabis |
| Organogenesis Holdings |
Aurora Cannabis and Organogenesis Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aurora Cannabis and Organogenesis Holdings
The main advantage of trading using opposite Aurora Cannabis and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aurora Cannabis position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.| Aurora Cannabis vs. Canopy Growth Corp | Aurora Cannabis vs. SNDL Inc | Aurora Cannabis vs. Cronos Group | Aurora Cannabis vs. Curaleaf Holdings |
| Organogenesis Holdings vs. Shuttle Pharmaceuticals | Organogenesis Holdings vs. Lifecore Biomedical | Organogenesis Holdings vs. Redhill Biopharma | Organogenesis Holdings vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |